Prof. Dr. Marco Durante is Director of the Biophysics Department at GSI Helmholtz Center for Heavy Ion Research (Darmstadt, Germany) and Full Professor of Physics at the Technical University of Darmstadt. He is also Adjunct Professor of Physics at the University of Naples Federico II in Italy, and at the Gunma College of Medicine in Japan. Dr. Durante got his Ph.D. in physics in 1992 at the University Federico II and has worked as postdoc at the Lawrence Berkeley Laboratory (Berkeley, CA, USA), NASA Lyndon B. Johnson Space Center (Houston, TX, USA), and NIRS-QST (Chiba, Japan). He is generally recognized as world leader in the field of particle radiobiology and medical physics and is co-author of over 45 papers in peer-reviewed scientific journals (h-index=59) and one patent on proton therapy (EU patent WO2013083333). He is currently chair of the the Particle Therapy Co-Operative Group (PTCOG). Dr. Durante was President of the International Association for Radiation Research (IARR) 2011-15, and is Associate Editor in several International scientific journals. He has received many grants to support his research, primarily by ESA, EU H2020, ERC, and BMBF and several awards for his research including the 2020 Failla award (RRS), 2013 Bacq & Alexander award (ERRS) and the 2013 IBA-Europhyscs award (EPS).